Ocuphire Pharma announced the appointments of Ash Jayagopal, Ph.D., M.B.A. as Chief Scientific and Development Officer, CSDO, and Nirav Jhaveri, C.F.A., M.B.A. as Chief Financial Officer, CFO, effective today. Prior to joining Ocuphire, Jayagopal served as the Chief Scientific Officer of Opus Genetics. Before joining Ocuphire, Jhaveri served as Chief Financial Officer of Insilico Medicine.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OCUP:
- Ocuphire Pharma Strengthens Leadership Team with Key Appointments
- Ocuphire Pharma announces presentation on APX3330
- Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 Conference
- Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Ocuphire Pharma files $175M mixed securities shelf